The Wistar Legacy Awards and 25th Jonathan Lax Lecture was a poignant night celebrating the people and organizations that 25 years ago came together from backgrounds in community activism, philanthropy, faith, government, law, and science to fight…
PHILADELPHIA—(October 14, 2021)—The Wistar Institute is proud to announce Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Jane Shull, chief executive officer of Ph…
Wistar’s scientific accomplishments could not be achieved without the support of our donors who recognize our research strengths, share our vision and are committed to tackling disease, improving human health and answering the most pressing scient…
Throughout its history, Wistar has successfully cultivated strategic relationships to accelerate the development of its discoveries toward the clinic. Recognizing that the potential of scientific discovery in biomedical research extends well beyon…
Dr. Luis Montaner is a transformative leader in HIV research. Throughout his tenure at Wistar, his discoveries to find an HIV cure have elevated both the prestige and scientific prowess of the Institute while most importantly, helped inform the tr…
Research in the Gene Expression & Regulation Program at Wistar continues to reveal new knowledge on RNA and its functions to regulate how our genes are expressed and how that can go awry. The advent of mRNA vaccines for COVID-19 — touted as th…
Companies that make rubella vaccines have been getting harder and harder to come by. The global production of the rubella vaccine, supplied in combination with measles, mumps and varicella vaccines, which is the typical route f…
PHILADELPHIA — (Sept. 22, 2021) —The Wistar Institute and Penn Medicine have been awarded a prestigious $11.7 million Specialized Programs of Research Excellence, or SPORE, grant from the National Cancer Institute. The five-year award will fund th…
PHILADELPHIA — (Sept. 21, 2021) — Mutations in the ARID1A gene are present in more than 50% of ovarian clear cell carcinomas (OCCC), for which effective treatments are lacking. Scientists at The Wistar Institute discovered that loss of ARID1A func…
Wistar welcomes Dr. Noam Auslander as an assistant professor in the Cancer Center’s Molecular & Cellular Oncogenesis Program. She applies artificial intelligence (AI) through high-throughput computer approaches to interpret the very large sets…
